Skip to search formSkip to main contentSkip to account menu

Hydroxyethylrutoside

Known as: beta-Hydroxyethylrutoside, hydroxyethylrutosides, 0-beta-Hydroxyethylrutoside 
Monohydroxyethyl derivative of rutin. Peripheral circulation stimulant used in treatment of venous disorders.
National Institutes of Health

Related topics

Related topics

18 relations

Narrower (9)

2-ethylrutoside7-monohydroxyethylrutosideRelveneVenalot
In BloodProcess of secretionagonistsanalogs & derivatives

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
16 Calcium Dobesilate in Prevention and Treatment of Diabetic Retinopathy Old
Diabetic retinopathy is a leading cause of adult vision loss and blindness. Angioprotective drugs are one of possibilities, which… 
2005
2005
Hydroxyethylrutoside zur Behandlung der chronischen Veneninsuffizienz Grad I und II
Zusammenfassung Nach wie vor zählt der Einsatz von Ödemprotektiva zu den wichtigen Therapieoptionen bei der chronischen… 
1986
1986
[Dosage of O-beta hydroxyethylrutoside in chronic venous insufficiency].
45 patients suffering from varicose veins with or without a chronic insufficiency up to stage II, took 1, 2 or 3 g of Oc-beta… 
1984
1984
A double-blind clinical trial of hydroxyethylrutosides in Menière's disease
A double-blind, placebo-controlled, cross-over trial was undertaken in 39 patients with well-defined Menière's disease. After a… 
1978
1978
Ergebnisse chromatographischer Untersuchungen an wasserlöslichen Rutosiden
Die wasserloslichen Rutoside Tetra-O-(β-hydroxyethyf)-rutosid1 (Tetra) und Tri-O-(β-hydroxyethyl)-rutosid1 (Tri) sind keine… 
1977
1977
Antithrombotic effects of some flavonoids alone and combined with acetylsalicylic acid.
In the rat, a selection of two experimental models of "prethrombotic states", one of venostatic thrombosis and one of arterial… 
1972
1972
Metabolism of the hydroxyethylrutosides. Biliary and urinary excretion of 3',4',5-(hydroxyethyl- 14 C), 7-tetra-O-( -hydroxyethyl)-rutoside in rats and monkeys after parenteral administration.
1. 3′,4′,5-[Hydroxyethyl-*C],7-tetra-O-(β-hydroxyethyl)rutosideis rapidly excreted unchanged, in both urine (42–71% dose in 24 h… 
1972
1972
The effect of hydroxyethylrutosides after acute and chronic oral administration in patients with venous diseases. A double-blind study.
1972
1972
Warfarin and hydroxyethylrutosides in deep vein thrombosis.
given in the accompanying Table, where it is shown that a group of persons known to have been infected with "Asian" H3N2 virus… 
1970
1970
Chronic venous insufficiency treated with hydroxyethylrutosides (HR).
The effect of hydroxyethylrutosides (HR) on a series of 64 patients is reported. All patients received 400 mg 3 times daily… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)